Prot #1315.2: An Open-Label, Phase I/II Trial To Determine The Maximum Tolerated Dose And Investigate Safety, Pharmacokinetics And Efficacy Of BI 836858 In Combination With Decitabine In Patients With Acute Myeloid Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date2/13/17 → 2/13/20

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1315.2)